Perceptive Advisors LLC Acer Therapeutics Inc. Transaction History

Perceptive Advisors LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 May 15, 2018	SELL	$14.81 - $20.22 $2.22 Million - $3.03 Million	-150,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.81 - $19.35 $1.77 Million - $2.9 Million	150,000	150,000 $2.09 Million

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.